In addition, CNS administration or viral overexpression of the soluble isoform of CX3CL1 diminishes brain damage in ischaemia and Parkinson's disease models49, 50, 51, consistent with the reduction of HFD-induced gliosis and weight gain observed in our experimental models. This evidence concerns the gene CX3CL1 and Parkinson disease.